← All organizations

Wyeth

For profitContributed to NMEWebsite ↗

Also known as: clinicaltrialinfo@wyeth.com | For Argentina, Chile, scheima@wyeth.com | For Argentina, Chile, scheima@wyeth.com, rendop@wyeth.com | For Argentina, Scheima@wyeth.com | For Argentina: Scheima@wyeth.com | For Argentina, scheima@wyeth.com or rendop@wyeth.com | For Australia and Hong Kong, medinfo@wyeth.com | For Australia, China, Hong Kong, medinfo@wyeth.com | For Australia, Korea, Taiwan, medinfo@wyeth.com | For Australia, medinfo@wyeth.com | For Australia, New Zealand, medinfo@wyeth.com | For Australia, Taiwan, medinfo@wyeth.com | For Austria, medinfo@wyeth.com | For Austria, WPVIMED@wyeth.com | For Belgium, trials-BEL@wyeth.com | For Belguim, trials-BEL@wyeth.com | For Brazil, xavierl@wyeth.com | For Canada, clintrialparticipation@wyeth.com | For Chile, scheima@wyeth.com | For Chile: scheima@wyeth.com | For China, medinfo@wyeth.com | For China: medinfo@wyeth.com | For Croatia, WPBUMED@wyeth.com | For Czech Republic, WPPGCLI@wyeth.com | For Denmark, Finland, MedInfoNord@wyeth.com | For Denmark, Finland, Norway, and Sweden, medinfonord@wyeth.com | For Denmark, Finland, Sweden, MedInfoNord@wyeth.com | For Denmark, Finland, Sweden, Norway, MedInfoNord@wyeth.com | For Denmark, medinfonord@wyeth.com | For Drug Consulting | For Estonia, Latvia, Lithuania, WPVIMED@wyeth.com | For Estonia, WVPMED@wyeth.com | For Finland, MedInfoNord@wyeth.com | For Finland, Sweden, MedInfoNord@wyeth.com | For France, infomedfrance@wyeth.com | For France: infomedfrance@wyeth.com | For Germany, medinfoDEU@wyeth.com | For Germany, MedinfoDEU@wyeth.com | For Germany, MedInfoDEU@wyeth.com | For Greece, decresg@wyeth.com | For Hong Kong, medinfo@wyeth.com | For Hong Kong: medinfo@wyeth.com | For Hungary, Croatia, WPBUMED@wyeth.com | For Hungary, WPBUMED@wyeth.com | For Hungary: WPBUMED@wyeth.com | For Ireland, ukmedinfo@wyeth.com | For Italy, decresg@wyeth.com | For Italy, descresg@wyeth.com | For Italy, Greece, decresg@wyeth.com | For Italy,Greece, decresg@wyeth.com | For Latvia, WPVIMED@wyeth.com | For Lithuania, WPVIMED@wyeth.com | For Mexico, gomezlj@wyeth.com | For Mexico, gomezzlj@wyeth.com | For Mexico: gomezzlj@wyeth.com | For Netherlands, trials-NL@wyeth.com | For New Zealand, medinfo@wyeth.com | For Norway, Finland, MedInfoNord@wyeth.com | For Norway, Sweden, MedInfoNord@wyeth.com | For Poland, WPWZMED@wyeth.com | For Poland: WPWZMED@wyeth.com | For Poland, WVWZMED@wyeth.com | For Portugal,Saudi Arabia, clintrialparticipation@wyeth.com | For Romania and Russia, WPVIMED@wyeth.com | For Romania, WPVIMED@wyeth.com | For Romania, WVPIMED@wyeth.com | For Russia, WVPIMED@wyeth.com | For Serbia, WPVIMED@wyeth.com | For Slovakia, DIS-WP-BV-EUBV01-Medical@wyeth.com | For South Africa, AZFinfo@wyeth.com | For South Africa, please contact ZAFinfo@wyeth.com | For South Africa, ZAFinfo@wyeth.com | For South Africa: ZAFinfo@wyeth.com | For Spain, infomed@wyeth.com | For Spain: infomed@wyeth.com | For Spain, Italy, Portugal, the Netherlands, and Finland, clinicaltrialinfo@wyeth.com | For Sweden and Denmark, MedInfoNord@wyeth.com | For Sweden, Denmark and Norway, MedInfoNord@wyeth.com | For Sweden, Finland,MedInfoNord@wyeth.com | For Sweden, MedInfoNord@wyeth.com | For Sweden: MedInfoNord@wyeth.com | For Switzerland, med@wyeth.com | For Taiwan, medinfo@wyeth.com | For Taiwan: medinfo@wyeth.com | For Turkey, Erisc@wyeth.com | For UK/Great Britian, ukmedinfo@wyeth.com | For UK/Great Britian: ukmedinfo@wyeth.com | For Ukraine, Romania, WPVIMED@wyeth.com | For Ukraine, WVPIMED@wyeth.com | For UK, ukmedinfo@wyeth.com | For UK, ukmedonfo@wyeth.com | For United Kingdom and Ireland, ukmedinfo@wyeth.com | For United Kingdom, ukmedinfo@wyeth.com | Wyeth | WYETH CONS | Wyeth-Lederle Vaccines | Wyeth Pharmaceuticals Inc. | Wyeth Pharmaceuticals LLC | WYETH PHARMS | WYETH PHARMS INC | Wyeth Reseach | Wyeth Reserach

Highest phase reached

Phase 4

First clinical trial

Jul 1, 1992

First marketed drug

May 8, 1942

First NDA

Oct 28, 1953

Last known activity

Oct 11, 2022

Acquired by American Home ProductsPfizer on Jan 1, 1931

Timeline

1860s

  1. Jul 1, 1860

    Wyeth— Founded

1930s

  1. Jan 1, 1931

    American Home Products— Acquired By

1950s

  1. Aug 23, 1957

    brompheniramine maleate— NDA Organization

1960s

  1. Apr 30, 1965

    ethionamide— NDA Secondary Org

1990s

  1. Dec 30, 1994

    medroxyprogesterone— Marketing Organization

2000s

  1. Oct 15, 2009

    Pfizer— Now

Drugs by trial phase (187 distinct, 513 trials)

Indications

Studied for

Marketed drugs (42)

Recent trials (50)

Details

Founded
Philadelphia, PA, US Jul 1, 1860
First NDA
Oct 28, 1953
Last known activity
Oct 11, 2022

Designations held

  • Orphan drug
  • Fast track
  • Priority review